A research team led by Min Zhang and Dabao Zhang from the University of California, Irvine’s Joe C. Wen School of Population & Public Health has produced the most detailed map to date of how genes directly influence one another inside brain cells affected by Alzheimer’s disease. Unlike earlier charts that only show which genes tend to move together, these new maps pinpoint the genes that actually drive activity in other genes across several brain cell types.
To build this resource, the scientists created a machine‑learning framework named SIGNET. While conventional tools stop at correlation, SIGNET is engineered to uncover true cause‑and‑effect links. Applying the platform, the group identified key biological pathways that may underlie memory loss and the slow erosion of brain tissue.
The results appear in Alzheimer's & Dementia: The Journal of the Alzheimer's Association. The study also highlights several newly recognized genes that could serve as promising targets for future drug development. The work was supported in part by the National Institute on Aging and the National Cancer Institute.
Why Gene‑Control Insights Matter for Alzheimer’s
Alzheimer’s remains the top cause of dementia and projections suggest nearly 14 million Americans may be living with the disease by 2060. Although researchers have linked a handful of genes—such as APOE and APP—to disease risk, the precise ways these genes disrupt normal brain function have remained vague.
How SIGNET Detects Causal Gene Relationships
For the map, the team examined single‑cell molecular data from brain tissue donated by 272 participants in the long‑term Religious Orders Study and the Rush Memory and Aging Project. SIGNET combines single‑cell RNA sequencing with whole‑genome sequencing, allowing it to scan the entire genome for directional gene‑to‑gene influences.
Using this approach, the researchers built causal gene‑regulatory networks for six major brain cell types, making it possible to spot which genes are likely steering the activity of many others—something correlation‑only methods cannot reliably achieve.
Major Rewiring Detected in Excitatory Neurons
The most striking disruptions emerged in excitatory neurons, the cells that transmit activating signals. Nearly 6,000 cause‑and‑effect interactions were uncovered, indicating extensive genetic rewiring as Alzheimer’s progresses.
Among these, hundreds of “hub” genes act as central regulators, influencing dozens of downstream targets. These hub genes represent attractive candidates for early diagnostic markers and therapeutic intervention. The analysis also revealed unexpected regulatory roles for well‑known genes like APP, which appears to strongly direct other genes in inhibitory neurons.
To bolster confidence in their findings, the investigators validated the networks using an independent set of human brain samples, confirming that the observed relationships reflect genuine biological mechanisms in Alzheimer’s disease.
Beyond Alzheimer’s, the SIGNET platform could be adapted to explore gene‑regulatory networks in other complex conditions, including various cancers, autoimmune disorders, and mental‑health illnesses.